Sparx Therapeutics
Business Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
700 E Business Center Dr, Mount Prospect...Phone Number
(959) 603-6035Website
www.sparxbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Sparx Therapeutics
SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company focused on enhancing human immunity through innovative antibody therapies, particularly in the field of immuno-oncology. The company specializes in the discovery and development of next-generation antibody-drug conjugates (ADCs) and multi-specific antibodies. Their integrated capabilities include biologics production, process development, and optimization, aimed at addressing the challenges in drug development. SparX targets clients in the healthcare sector, particularly those involved in cancer treatment and immunotherapy.Explore more
Sparx Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sparx Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sparx Therapeutics has new funding data
Sparx Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Sparx Therapeutics recently announced quarterly report
Check if Sparx Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Sparx Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sparx Therapeutics
Check out if Sparx Therapeutics is spiking on competitors!
Product Launch: Get notified when Sparx Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Sparx Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Sparx Therapeutics
Compare insights from companies similar to Sparx Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sparx Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sparx Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sparx Therapeutics.
Sparx Therapeutics Tech Stack
A closer look at the technologies used by Sparx Therapeutics
See more technologies
Most Recent Scoops
Open Position
New Hire
Executive Move
Open Position
Open Position
Sparx Therapeutics News & Media
SparX to Present Phase 1 Clinical Updates of SPX-303, a Dual Checkpoint Bispecific Antibody, at Two Events During AACR 2025
CHICAGO, April 18, 2025 /PRNewswire/ -- SparX Biopharmaceutical Corp. announced today that it will present clinical updates on its lead asset, SPX-303, a first-in-class anti-LILRB2/PD-L1 bispecific antibody, during the Trial-in-Progress poster session at the 2025 American Association for...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Sparx Therapeutics
Sign Up For FreeTo access detailed company insights
SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company focused on enhancing human immunity through innovative antibody therapies, particularly in the field of immuno-oncology. The company specializes in the discovery and development of next-generation antibody-drug conjugates (ADCs) and multi-specific antibodi... Read More
